N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide

C19H26N2O3 — CID 111113210

IUPACN-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide
SMILESO=C(NC1CCC(O)CC1)C(c1ccccc1)N1CCCCC1=O
InChIInChI=1S/C19H26N2O3/c22-16-11-9-15(10-12-16)20-19(24)18(14-6-2-1-3-7-14)21-13-5-4-8-17(21)23/h1-3,6-7,15-16,18,22H,4-5,8-13H2,(H,20,24)
InChIKeyKMORJSQATULDIU-UHFFFAOYSA-N
MW330.43 g/mol
LogP2.16
Rot. Bonds4

About N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide

N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide (PubChem CID 111113210) has the molecular formula C19H26N2O3 and a molecular weight of 330.43 g/mol. Its IUPAC name is N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide.

Molecular Properties

Compound NameN-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide
PubChem CID111113210
Molecular FormulaC19H26N2O3
Molecular Weight330.43 g/mol
Exact Mass330.19
IUPAC NameN-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide
SMILESO=C(NC1CCC(O)CC1)C(c1ccccc1)N1CCCCC1=O
InChIInChI=1S/C19H26N2O3/c22-16-11-9-15(10-12-16)20-19(24)18(14-6-2-1-3-7-14)21-13-5-4-8-17(21)23/h1-3,6-7,15-16,18,22H,4-5,8-13H2,(H,20,24)
InChIKeyKMORJSQATULDIU-UHFFFAOYSA-N
XLogP2.16
TPSA69.64 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500330.43
LogP ≤ 52.16
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Analyze N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(4-aminocyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide
CID 119476626
N-(cyclopropylmethyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide
CID 56515214
N-cyclopentyl-4-[[2-(2-oxopiperidin-1-yl)-2-phenylacetyl]amino]benzamide
CID 56513712
N-[1-[(3-methylphenyl)methyl]piperidin-4-yl]-2-(2-oxopiperidin-1-yl)-2-phenylacetamide
CID 56505309
N-[(1S,4R)-4-(hydroxymethyl)cyclopent-2-en-1-yl]-2-(2-oxopiperidin-1-yl)-2-phenylacetamide
CID 111661791
N-methyl-2-(2-oxopyrrolidin-1-yl)-2-phenylacetamide
CID 123551367
N-(3-cyclopentylpropyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide
CID 56577591
2-(2-oxopiperidin-1-yl)-2-phenyl-N-[1-(4-propan-2-ylphenyl)ethyl]acetamide
CID 56574475
N-(3-aminopropyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide;hydrochloride
CID 119406812
3-[[2-(2-oxopiperidin-1-yl)-2-phenylacetyl]amino]benzoic acid
CID 119219540
N-(3-cyclopentyloxyphenyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide
CID 56515228
(3R)-1-[(2S)-2-(2-oxopiperidin-1-yl)-2-phenylacetyl]piperidine-3-carboxylic acid
CID 99638802

Frequently Asked Questions

What is the IUPAC name of N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide?
The IUPAC name of N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide (CID 111113210) is N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide.
What is the SMILES notation for N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide?
The canonical SMILES for N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide is O=C(NC1CCC(O)CC1)C(c1ccccc1)N1CCCCC1=O.
What is the InChIKey of N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide?
The InChIKey is KMORJSQATULDIU-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H26N2O3/c22-16-11-9-15(10-12-16)20-19(24)18(14-6-2-1-3-7-14)21-13-5-4-8-17(21)23/h1-3,6-7,15-16,18,22H,4-5,8-13H2,(H,20,24).
What are the key properties of N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide?
N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide has a molecular weight of 330.43 g/mol, XLogP of 2.16, 4 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-(4-hydroxycyclohexyl)-2-(2-oxopiperidin-1-yl)-2-phenylacetamide is sourced from PubChem (CID 111113210), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).